05.05.2010 - Anglo-Swedish drugmaker Astrazeneca is aggressively meeting potential acquisition partners to fill as it prepares for generic competition from some of its best-selling drugs. "We...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)